News & Events
Your location:
Home
/
/
2019

2019

  • Categories:Milestones
  • Time of issue:2019-11-27
  • Views:0

(Summary description)• Subsidiary HMYA Established, International Business Operated Independently
• EU & FDA Application Submitted
• Top 20 Chinese Pharmaceutical R&D Companies Awarded (Reelected)
• CSAIII Pilot
• T100 New Technology & New Product Innovation Action Outstanding Enterprise Awarded

2019

(Summary description)• Subsidiary HMYA Established, International Business Operated Independently
• EU & FDA Application Submitted
• Top 20 Chinese Pharmaceutical R&D Companies Awarded (Reelected)
• CSAIII Pilot
• T100 New Technology & New Product Innovation Action Outstanding Enterprise Awarded

  • Categories:Milestones
  • Time of issue:2019-11-27
  • Views:0
Information

Subsidiary HMYA Established, International Business Operated Independently

EU & FDA Application Submitted

Top 20 Chinese Pharmaceutical R&D Companies Awarded (Reelected)

CSAIII Pilot

T100 New Technology & New Product Innovation Action Outstanding Enterprise Awarded

Scan the QR code to read on your phone

Previous: 2020
Next: 2018
Previous: 2020
Next: 2018

  

Beijing Hope Pharmaceutical Co., Ltd.   京ICP證000000号

這是描述信息